Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2024年8月6日

• Piero Barbanti,
• Gabriella Egeo,
• Stefania Proietti,
• Florindo d’Onofrio,
• Cinzia Aurilia,
• Cinzia Finocchi,
• Laura Di Clemente,
• Maurizio Zucco,
• Alberto Doretti,
• Stefano Messina,
• Massimo Autunno,
• Angelo Ranieri,
• Antonio Carnevale,
• Bruno Colombo,
• Massimo Filippi,
• Miriam Tasillo,
• Steno Rinalduzzi,
• Pietro Querzani,
• Giuliano Sette,
• Lorenzo Forino,
• Francesco Zoroddu,
• Micaela Robotti,
• Alessandro Valenza,
• Cecilia Camarda,
• Laura Borrello,
• Marco Aguggia,
• Giovanna Viticchi,
• Carlo Tomino,
• Giulia Fiorentini,
• Bianca Orlando,
• Stefano Bonassi,
• Paola Torelli